Study to Assess the Blood Levels and Safety of AZD9291 in Patients With Advanced Solid Tumours and Normal Liver Function or Mild or Moderate Liver Impairment

NCT02161770 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumours

Interventions

DRUG: AZD9291 tablet dosing
PROCEDURE: Pharmacokinetic sampling - AZD9291
PROCEDURE: Pharmacokinetic sampling - AZ5140 and AZ7550

Sponsor

AstraZeneca